NCT03536637View on ClinicalTrials.gov

DMT310-001 Topical in the Treatment of Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 22, 2018

Primary Completion Date

December 30, 2018

Study Completion Date

January 28, 2019

Conditions
Acne Vulgaris
Interventions
DRUG

DMT310

Topical Powder

DRUG

Hydrogen Peroxide

Liquid Diluent

DRUG

Placebo

Placebo Topical Powder

Trial Locations (9)

27262

Dermata Investigational Site, High Point

37215

Dermata Investigational Site, Tennessee City

64506

Dermata Investigational Site, Saint Joseph

77494

Dermata Investigational Site, Katy

77802

Dermata Investigational Site, College Station

78759

Dermata Investigational Site, Austin

87106

Dermata Investigational Site, Albuquerque

89148

Dermata Investigational Site, Henderson

92123

Dermata Investigational Site, San Diego

Sponsors
All Listed Sponsors
lead

Dermata Therapeutics

INDUSTRY

NCT03536637 - DMT310-001 Topical in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter